Florida Restores Access to Low-Cost H.I.V. Medications After Uproar
A short-term funding bill enacted this week will ensure that [...]
A new report from Assembled…
A new report from Assembled Intelligence and inVibe sheds light [...]
The FDA has given the all-clear to…
The FDA has given the all-clear to Corcept’s class-first Lifyorli [...]
Maze Therapeutics has revealed…
Maze Therapeutics has revealed topline phase 2 data for its [...]
Merck and Terns Pharmaceuticals…
Merck and Terns Pharmaceuticals have agreed to a $6.7 billion [...]
Sarepta Therapeutics has shared…
Sarepta Therapeutics has shared initial clinical data on two siRNA [...]
UCB will build a new manufacturing…
UCB will build a new manufacturing facility near its U.S. [...]
Abivax has appointed Michael…
Abivax has appointed Michael Nesrallah as its chief commercial officer, [...]
The FDA this month issued a…
The FDA this month issued a warning letter to ImmunityBio [...]
Full 12-month data from Ocugen’s…
Full 12-month data from Ocugen’s phase 2 eye disease gene [...]